Searching for the human genetic factors standing in the way of universally effective vaccines.

作者: Alexander J. Mentzer , Daniel O'Connor , Andrew J. Pollard , Adrian V. S. Hill

DOI: 10.1098/RSTB.2014.0341

关键词:

摘要: Vaccines have revolutionized modern public health. The effectiveness of some vaccines is limited by the variation in response observed between individuals and across populations. There compelling evidence that a significant proportion this variability can be attributed to human genetic variation, especially for those administered early life. Identifying understanding determinants could far-reaching influence upon future methods vaccine design deployment. In review, we summarize studies been undertaken attempting identify heterogeneity against hepatitis B, measles rubella. We offer critical appraisal these make series suggestions about how techniques, including genome-wide association studies, used characterize architecture heterogeneity. conclude suggesting findings from such translated improve target vaccination more cost-effective manner.

参考文章(97)
Monika Lindemann, Vahé Barsegian, Winfried Siffert, Stanislav Ferencik, Michael Roggendorf, Hans Grosse-Wilde, Role of G Protein β3 Subunit C825T and HLA Class II Polymorphisms in the Immune Response after HBV Vaccination Virology. ,vol. 297, pp. 245- 252 ,(2002) , 10.1006/VIRO.2002.1467
I. Desombere, T. Cao, Y. Gijbels, G. Leroux-Roels, Non‐responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co‐stimulation Clinical and Experimental Immunology. ,vol. 140, pp. 126- 137 ,(2005) , 10.1111/J.1365-2249.2004.02749.X
Neelam Dhiman, Inna G. Ovsyannikova, Robert A. Vierkant, Jenna E. Ryan, V. Shane Pankratz, Robert M. Jacobson, Gregory A. Poland, Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary results Vaccine. ,vol. 26, pp. 1731- 1736 ,(2008) , 10.1016/J.VACCINE.2008.01.017
Tzu-Wei Wu, Chen-Chung Chu, Tzu-Ying Ho, Huei-Wen Chang Liao, Sheng-Kai Lin, Marie Lin, Hans Hsienhong Lin, Li-Yu Wang, Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents Human Genetics. ,vol. 132, pp. 1131- 1139 ,(2013) , 10.1007/S00439-013-1320-5
S Davila, FEM Froeling, A Tan, C Bonnard, GJ Boland, H Snippe, ML Hibberd, M Seielstad, None, New genetic associations detected in a host response study to hepatitis B vaccine. Genes and Immunity. ,vol. 11, pp. 232- 238 ,(2010) , 10.1038/GENE.2010.1
Iana H. Haralambieva, Inna G. Ovsyannikova, Benjamin J. Umlauf, Robert A. Vierkant, V. Shane Pankratz, Robert M. Jacobson, Gregory A. Poland, Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine. ,vol. 29, pp. 8988- 8997 ,(2011) , 10.1016/J.VACCINE.2011.09.043
Bjarke Feenstra, Björn Pasternak, Frank Geller, Lisbeth Carstensen, Tongfei Wang, Fen Huang, Jennifer L Eitson, Mads V Hollegaard, Henrik Svanström, Mogens Vestergaard, David M Hougaard, John W Schoggins, Lily Yeh Jan, Mads Melbye, Anders Hviid, Common variants associated with general and MMR vaccine-related febrile seizures Nature Genetics. ,vol. 46, pp. 1274- 1282 ,(2014) , 10.1038/NG.3129
L.-C. Hsu, S.-R. Lin, H.-M. Hsu, W.-H. Chao, J.-T. Hsieh, M.-C. Wang, C.-F. Lu, Y.-H. Chang, M.-S. Ho, Ethnic Differences in Immune Responses to Hepatitis B Vaccine American Journal of Epidemiology. ,vol. 143, pp. 718- 724 ,(1996) , 10.1093/OXFORDJOURNALS.AJE.A008805
Branwen J. Hennig, Katherine Fielding, John Broxholme, Mathurin Diatta, Maimuna Mendy, Catrin Moore, Andrew J. Pollard, Pura Rayco-Solon, Giorgio Sirugo, Marianne A. van der Sande, Pauline Waight, Hilton C. Whittle, Syed M. Zaman, Adrian V. Hill, Andrew J. Hall, Host genetic factors and vaccine-induced immunity to hepatitis B virus infection PLOS ONE. ,vol. 3, ,(2008) , 10.1371/JOURNAL.PONE.0001898
James D. Cherry, Epidemic Pertussis in 2012 — The Resurgence of a Vaccine-Preventable Disease New England Journal of Medicine. ,vol. 367, pp. 785- 787 ,(2012) , 10.1056/NEJMP1209051